BioSpace News Archive

InDex Pharmaceuticals Holding AB announces that an independent DMC has completed the planned dose selection analysis including safety review and assessment for futility in Induction Study 1 of the phase III program CONCLUDE.

Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the upcoming 35th Annual Piper Sandler Healthcare Conference.

Inventiva reported financial information for the nine months ended September 30, 2023.

89bio, Inc. (Nasdaq: ETNB) today announced that the Company’s Management will participate in a fireside chat at the 6th Annual Evercore HEALTHCONx Conference on Tuesday, November 28, 2023 at 8:45 AM ET and participate in one-on-one investor meetings.

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in a fireside discussion at the Piper Sandler Healthcare Conference on November 28, 2023 at 10:00am.

Ardelyx, Inc. announced that on November 20, 2023, the compensation committee of the company’s board of directors granted fourteen new non-executive employees options to purchase an aggregate of 221,805 shares of the company’s common stock, and granted sixteen new non-executive employees an aggregate of 182,068 Restricted Stock Units.

Sutro Biopharma, Inc., a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates, announced the promotion of Jane Chung to President and Chief Operating Officer, a newly created role, effective December 1, 2023.

Alkermes plc announced that management will participate in fireside chat presentations at two upcoming investor conferences.

Kezar Life Sciences, Inc. (Nasdaq: KZR) today announced that Chris Kirk, Co-founder and Chief Executive Officer, will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023, at 1:20 pm ET in Miami, FL.

Apotex Corp. announced the launch of Teriparatide Injection, a single-patient-use pre-filled pen used for the treatment of osteoporosis in the United States.